Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer
Sponsor: Icahn School of Medicine at Mount Sinai
Terminated
No Current Funding
Other terminated trials from Icahn School of Medicine at Mount Sinai
- Migraine Headaches · Feb 2026
- Coronary Artery Disease · Phase NA · Oct 2025
- CTCL · Phase PHASE2 · Jun 2025
- Peripartum Anemia · Phase NA · Jun 2025
- Pleural Disease · Phase PHASE3 · Mar 2025
See all terminations from Icahn School of Medicine at Mount Sinai
Other Colon Cancer trials with similar outcome
A NA clinical study on Colon Cancer and Medullary Thyroid Cancer, this trial is terminated or withdrawn. The trial is conducted by Icahn School of Medicine at Mount Sinai and has accumulated 11 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Sep 2022 — Jul 2024 [monthly]
Terminated NA
Status: Suspended → Terminated
-
Jan 2021 — Sep 2022 [monthly]
Suspended NA
-
Nov 2020 — Jan 2021 [monthly]
Suspended NA
Status: Enrolling By Invitation → Suspended
▶ Show 6 earlier versions
-
Aug 2019 — Nov 2020 [monthly]
Enrolling By Invitation NA
-
Aug 2018 — Aug 2019 [monthly]
Enrolling By Invitation NA
-
Jun 2018 — Aug 2018 [monthly]
Enrolling By Invitation NA
-
Aug 2017 — Jun 2018 [monthly]
Enrolling By Invitation NA
-
Feb 2017 — Aug 2017 [monthly]
Enrolling By Invitation NA
Phase: PHASE2 → NA
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation PHASE2
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Icahn School of Medicine at Mount Sinai
For direct contact, visit the study record on ClinicalTrials.gov .